Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05608694 · ClinicalTrials.gov registry record · NA
MRI Screening in Men at High Risk of Developing Prostate Cancer
A NA study of Prostate Cancer Screening, sponsored by University of Chicago.
- Recruiting
- Registry status
- NA
- Development phase
- 250
- Enrollment target
- 2
- Study locations
NCT05608694 is a NA study of Prostate Cancer Screening that is actively recruiting participants, run by University of Chicago. The registered enrollment target is 250 participants. The trial reports 2 study locations across 1 state.
The verdict
NCT05608694, a NA study of Prostate Cancer Screening, is actively recruiting participants, sponsored by University of Chicago.
- RECRUITING
- Registry status
- NA
- Development phase
- 250 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this study is to determine whether or not Magnetic Resonance Images (MRI) will identify high-grade cancers earlier and more frequently in men at high risk of developing prostate cancer.
Conditions Studied
Interventions
- OTHER Prostate MRI
Study Locations (2)
Illinois
- University of Chicago - Chicago
- NorthShore University Health System - Glenbrook Hospital - Glenview
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 250 participants |
| Start Date | 2022-03-02 |
| Est. Completion | 2039-03-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05608694
The ClinicalTrials.gov registry entry for NCT05608694 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 250 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Chicago, which has 796 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Prostate Cancer Screening appearing as the primary indexed condition, and to 1 intervention - of which Prostate MRI is the first listed.
NCT05608694 reports 2 study locations spanning 1 distinct geographic area - top geographies include Illinois.
Frequently Asked Questions
What is clinical trial NCT05608694 about?
NCT05608694 is a clinical study titled "MRI Screening in Men at High Risk of Developing Prostate Cancer". The purpose of this study is to determine whether or not Magnetic Resonance Images (MRI) will identify high-grade cancers earlier and more frequently in men at high risk of developing prostate cancer.
What is the current status of trial NCT05608694?
This trial is currently recruiting. It is a NA study. The enrollment target is 250 participants. The study started on 2022-03-02. Estimated completion is 2039-03-01.
What conditions does trial NCT05608694 study?
This clinical trial studies the following conditions: Prostate Cancer Screening.
What interventions are being tested in trial NCT05608694?
The interventions under investigation include: Prostate MRI (OTHER).
Who is sponsoring clinical trial NCT05608694?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05608694 being conducted?
This trial has 2 study locations across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Prostate Cancer Screening
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.